Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01821417 · ClinicalTrials.gov registry record · NA
Performance of MicroTextured Dental Implants
A NA study of Partially Edentulous Jaw, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT01821417: Completed NA study of Partially Edentulous Jaw, sponsored by University of Alabama at Birmingham.
NCT01821417 is a NA study of Partially Edentulous Jaw that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01821417, a NA study of Partially Edentulous Jaw, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will compare initial peri-implant bone healing and longitudinal osseointegration between a fully microtextured dental implant and an analogous implant with a smooth machined collar. The investigators hypothesize the fully textured implant will result in less peri-implant crestal bone resorption than the implant with a machined collar.
Primary Outcome
Using radiographic images and image-processing software, measurements of bone height at the mesial and distal of each implant will be captured in millimeters.
Conditions Studied
Interventions
- DEVICE Microtextured dental implant treatment
- DEVICE Dental implant treatment
Study Locations (1)
Alabama
- University of Alabama at Birmingham School of Dentistry - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01821417 record still lists
NCT01821417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Partially Edentulous Jaw appearing as the primary indexed condition, and to 2 interventions - of which Microtextured dental implant treatment is the first listed.
NCT01821417 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT01821417 about?
NCT01821417 is a clinical study titled "Performance of MicroTextured Dental Implants". The study will compare initial peri-implant bone healing and longitudinal osseointegration between a fully microtextured dental implant and an analogous implant with a smooth machined collar. The investigators hypothesize the fully textured implant will result in less peri-implant crestal bone reso...
What is the current status of trial NCT01821417?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-05. Estimated completion is 2015-10.
What conditions does trial NCT01821417 study?
This clinical trial studies the following conditions: Partially Edentulous Jaw.
What interventions are being tested in trial NCT01821417?
The interventions under investigation include: Microtextured dental implant treatment (DEVICE), Dental implant treatment (DEVICE).
Who is sponsoring clinical trial NCT01821417?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01821417 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01821417's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia